Blackrock Health Sciences Trust (NYSE:BME) Receives New Coverage from Analysts at Shore Capital

Stock analysts at Shore Capital initiated coverage on shares of Blackrock Health Sciences Trust (NYSE:BME) in a research report issued to clients and investors on Friday, Stock Target Advisor reports. The brokerage set a “buy” rating and a $429.00 price target on the stock.

Shares of NYSE BME traded up $0.02 during trading hours on Friday, hitting $39.13. 20,409 shares of the company’s stock were exchanged, compared to its average volume of 31,259. Blackrock Health Sciences Trust has a 1-year low of $32.00 and a 1-year high of $42.49. The company’s 50-day moving average price is $38.28 and its 200-day moving average price is $38.12.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Janney Montgomery Scott LLC lifted its position in shares of Blackrock Health Sciences Trust by 2.1% during the 3rd quarter. Janney Montgomery Scott LLC now owns 14,445 shares of the company’s stock worth $553,000 after purchasing an additional 300 shares during the last quarter. Commonwealth Equity Services LLC lifted its position in shares of Blackrock Health Sciences Trust by 3.7% during the 3rd quarter. Commonwealth Equity Services LLC now owns 11,748 shares of the company’s stock worth $449,000 after purchasing an additional 424 shares during the last quarter. BB&T Securities LLC lifted its position in shares of Blackrock Health Sciences Trust by 5.4% during the 2nd quarter. BB&T Securities LLC now owns 20,771 shares of the company’s stock worth $807,000 after purchasing an additional 1,062 shares during the last quarter. Cetera Advisor Networks LLC lifted its position in shares of Blackrock Health Sciences Trust by 11.4% during the 2nd quarter. Cetera Advisor Networks LLC now owns 15,321 shares of the company’s stock worth $597,000 after purchasing an additional 1,567 shares during the last quarter. Finally, Rikoon Group LLC lifted its position in shares of Blackrock Health Sciences Trust by 11.3% during the 3rd quarter. Rikoon Group LLC now owns 18,951 shares of the company’s stock worth $725,000 after purchasing an additional 1,928 shares during the last quarter.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Blackrock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Featured Story: Futures Contract

Stock Target Advisor

Leave a Reply

Your email address will not be published. Required fields are marked *

*